Connectome dysfunction in patients at clinical high risk for psychosis and modulation by oxytocin
View ORCID ProfileCathy Davies, View ORCID ProfileDaniel Martins, View ORCID ProfileOttavia Dipasquale, View ORCID ProfileRobert A. McCutcheon, Andrea De Micheli, Valentina Ramella-Cravaro, Umberto Provenzani, View ORCID ProfileGrazia Rutigliano, Marco Cappucciati, View ORCID ProfileDominic Oliver, View ORCID ProfileSteve Williams, View ORCID ProfileFernando Zelaya, View ORCID ProfilePaul Allen, Silvia Murguia, David Taylor, View ORCID ProfileSukhi Shergill, Paul Morrison, View ORCID ProfilePhilip McGuire, View ORCID ProfileYannis Paloyelis, View ORCID ProfilePaolo Fusar-Poli
doi: https://doi.org/10.1101/2023.03.17.23286528
Cathy Davies
1Early Psychosis: Interventions & Clinical-detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK
2Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK
3Department of Neuroimaging, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK
Daniel Martins
3Department of Neuroimaging, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK
4National Institute for Health Research (NIHR) Biomedical Research Centre (BRC), South London and Maudsley NHS Foundation Trust, London, UK
Ottavia Dipasquale
3Department of Neuroimaging, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK
Robert A. McCutcheon
2Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK
5Department of Psychiatry, University of Oxford, Oxford, UK
Andrea De Micheli
1Early Psychosis: Interventions & Clinical-detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK
4National Institute for Health Research (NIHR) Biomedical Research Centre (BRC), South London and Maudsley NHS Foundation Trust, London, UK
Valentina Ramella-Cravaro
1Early Psychosis: Interventions & Clinical-detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK
Umberto Provenzani
1Early Psychosis: Interventions & Clinical-detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK
6Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy
Grazia Rutigliano
1Early Psychosis: Interventions & Clinical-detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK
Marco Cappucciati
1Early Psychosis: Interventions & Clinical-detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK
Dominic Oliver
1Early Psychosis: Interventions & Clinical-detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK
5Department of Psychiatry, University of Oxford, Oxford, UK
Steve Williams
3Department of Neuroimaging, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK
Fernando Zelaya
3Department of Neuroimaging, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK
Paul Allen
2Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK
7Department of Psychology, University of Roehampton, London, UK
8Icahn School of Medicine, Mount Sinai Hospital, New York, NY, USA
Silvia Murguia
9Tower Hamlets Early Detection Service, East London NHS Foundation Trust, London, UK
David Taylor
10Institute of Pharmaceutical Science, King’s College London, London, UK
Sukhi Shergill
2Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK
Paul Morrison
2Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK
Philip McGuire
5Department of Psychiatry, University of Oxford, Oxford, UK
11NIHR Oxford Health Biomedical Research Centre, Oxford, UK
12Oxford Health NHS Foundation Trust, Oxford, UK
Yannis Paloyelis
3Department of Neuroimaging, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK
Paolo Fusar-Poli
1Early Psychosis: Interventions & Clinical-detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK
4National Institute for Health Research (NIHR) Biomedical Research Centre (BRC), South London and Maudsley NHS Foundation Trust, London, UK
6Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy
13Outreach And Support in South London (OASIS) Service, South London and Maudsley NHS Foundation Trust, London, UK
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Posted March 21, 2023.
Connectome dysfunction in patients at clinical high risk for psychosis and modulation by oxytocin
Cathy Davies, Daniel Martins, Ottavia Dipasquale, Robert A. McCutcheon, Andrea De Micheli, Valentina Ramella-Cravaro, Umberto Provenzani, Grazia Rutigliano, Marco Cappucciati, Dominic Oliver, Steve Williams, Fernando Zelaya, Paul Allen, Silvia Murguia, David Taylor, Sukhi Shergill, Paul Morrison, Philip McGuire, Yannis Paloyelis, Paolo Fusar-Poli
medRxiv 2023.03.17.23286528; doi: https://doi.org/10.1101/2023.03.17.23286528
Connectome dysfunction in patients at clinical high risk for psychosis and modulation by oxytocin
Cathy Davies, Daniel Martins, Ottavia Dipasquale, Robert A. McCutcheon, Andrea De Micheli, Valentina Ramella-Cravaro, Umberto Provenzani, Grazia Rutigliano, Marco Cappucciati, Dominic Oliver, Steve Williams, Fernando Zelaya, Paul Allen, Silvia Murguia, David Taylor, Sukhi Shergill, Paul Morrison, Philip McGuire, Yannis Paloyelis, Paolo Fusar-Poli
medRxiv 2023.03.17.23286528; doi: https://doi.org/10.1101/2023.03.17.23286528
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (200)
- Cardiovascular Medicine (2918)
- Dermatology (249)
- Emergency Medicine (438)
- Epidemiology (12711)
- Forensic Medicine (12)
- Gastroenterology (827)
- Genetic and Genomic Medicine (4567)
- Geriatric Medicine (415)
- Health Economics (726)
- Health Informatics (2913)
- Health Policy (1068)
- Hematology (386)
- HIV/AIDS (922)
- Medical Education (422)
- Medical Ethics (115)
- Nephrology (467)
- Neurology (4335)
- Nursing (234)
- Nutrition (636)
- Oncology (2261)
- Ophthalmology (643)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (278)
- Palliative Medicine (83)
- Pathology (499)
- Pediatrics (1196)
- Primary Care Research (494)
- Public and Global Health (6916)
- Radiology and Imaging (1524)
- Respiratory Medicine (915)
- Rheumatology (436)
- Sports Medicine (383)
- Surgery (486)
- Toxicology (60)
- Transplantation (210)
- Urology (178)